Suicide risk and symptom reduction in patients assigned to placebo in duloxetine and escitalopram clinical trials: analysis of the FDA summary basis of approval reports.
about
A systematic review of comparative efficacy of treatments and controls for depressionObservational study on safety and tolerability of duloxetine in the treatment of female stress urinary incontinence in German routine practice.Treatment of refractory angina in patients not suitable for revascularization.
P2860
Suicide risk and symptom reduction in patients assigned to placebo in duloxetine and escitalopram clinical trials: analysis of the FDA summary basis of approval reports.
description
2007 nî lūn-bûn
@nan
2007 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Suicide risk and symptom reduc ...... ary basis of approval reports.
@ast
Suicide risk and symptom reduc ...... ary basis of approval reports.
@en
Suicide risk and symptom reduc ...... ary basis of approval reports.
@nl
type
label
Suicide risk and symptom reduc ...... ary basis of approval reports.
@ast
Suicide risk and symptom reduc ...... ary basis of approval reports.
@en
Suicide risk and symptom reduc ...... ary basis of approval reports.
@nl
prefLabel
Suicide risk and symptom reduc ...... ary basis of approval reports.
@ast
Suicide risk and symptom reduc ...... ary basis of approval reports.
@en
Suicide risk and symptom reduc ...... ary basis of approval reports.
@nl
P921
P1476
Suicide risk and symptom reduc ...... ary basis of approval reports.
@en
P2093
Kelly Schwartz
P356
10.1080/10401230601163550
P577
2007-01-01T00:00:00Z